Companies: 10,795·Total market cap: $144.5T

Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics, Inc.

EMHTFOTCHealthcare

$0.04

+$0.01(+55.17%)

Market Cap$0

P/E Ratio—

52W High$0.0681

52W Low$0.02

Avg Volume93K

Open$0.03

Beta0.63

Emerald Health Therapeutics, Inc. (EMHTF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

EMHTF · net income · updated Jun 9, 2026

Core profitability metrics

EMHTF · net income · margin · TTM · CAGR

Net income was −$39.9M for FY2021 (fiscal year ending 2021-12-31), up 8.4% year-over-year. Net profit margin was -411.9%.

FY2021 Net Income−$39.9M▲ +8.4% YoY

Trailing 12M (TTM)−$29.9Mtrailing 4 quarters sum

Net Profit Margin-411.9%−$39.9M ÷ $9.7M

YoY Change+8.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · EMHTF net income history · EMHTF profit margin

Annual net income data

EMHTF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2021Loss−$39.9M▲ +8.4%-411.9%$9.7M

FY2020Loss−$43.5M▲ +61.1%-370.9%$11.7M

FY2019Loss−$111.9M▼ 261.2%-550.8%$20.3M

FY2018Loss−$31.0M▼ 254.8%-1590.5%$1.9M

FY2017Loss−$8.7M▼ 193.0%-931.3%$937,654

Net income vs peers (Healthcare)

EMHTF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Emerald Health Therapeutics, Inc.YOU

EMHTF

−$39.9M+8.4%-411.9%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Emerald Health Therapeutics, Inc. (EMHTF) reported net income of −$39.9M for FY2021 (fiscal year ending 2021-12-31), up 8.4% year-over-year. The net profit margin was -411.9% — meaning the company kept $-4.12 of every dollar of revenue as profit.

Emerald Health Therapeutics, Inc. has not yet achieved annual profitability based on available data (13 fiscal years). The company has reported net losses across all available periods.

Emerald Health Therapeutics, Inc.'s net profit margin was -411.9% for FY2021, based on the latest annual results.

Investors sometimes search for "Emerald Health Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from EMHTF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

EMHTF net income · 4 questions

Emerald Health Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $39.9M for FY2021.

is EMHTF profitabledoes EMHTF make a profitEMHTF profitabilityEMHTF profitable company

▸ Source: FMP /income-statement · GAAP · Emerald Health Therapeutics, Inc. · Emerald Health Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026